ID
22460
Description
Study part: PGx- Pharmacogenetic Research.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.
Keywords
Versions (1)
- 6/5/17 6/5/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
June 5, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Pharmacogenetic Research Mepolizumab HES NCT00086658
PGx- Pharmacogenetic Research
- StudyEvent: ODM
Description
BLOOD SAMPLE COLLECTION (DNA)
Alias
- UMLS CUI-1
- C0005834
Description
WITHDRAWAL OF CONSENT
Alias
- UMLS CUI-1
- C1707492
Description
BLOOD SAMPLE DESTRUCTION
Alias
- UMLS CUI-1
- C1948029
- UMLS CUI-2
- C0178913
Description
BLOOD SAMPLE DESTRUCTION
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1948029
- UMLS CUI [1,2]
- C0178913
Description
reason BLOOD SAMPLE DESTRUCTION
Data type
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C1948029
- UMLS CUI [1,3]
- C0178913
Description
Other
Data type
text
Alias
- UMLS CUI [1]
- C0205394
Similar models
PGx- Pharmacogenetic Research
- StudyEvent: ODM
C2347500 (UMLS CUI-2)
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,2])
C0178913 (UMLS CUI-2)
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
No comments